Lansoprazole vs Tofacitinib
Lansoprazole vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Lansoprazole and Tofacitinib.
Mechanism of Action
Lansoprazole: Proton pump inhibitor.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Lansoprazole — 1.5 hours; Tofacitinib — 3.2 hours.
Chemical Properties
Molecular Formula: Lansoprazole — C16H14F3N3O2S; Tofacitinib — C16H20N6O.
Molecular Weight: Lansoprazole — 369.3620 g/mol; Tofacitinib — 312.3700 g/mol.
Type: Lansoprazole — Small molecule; Tofacitinib — Small molecule.